
Loading, please wait...

Loading, please wait...

Researchers recently used whole exome sequencing to uncover significant HNSCC genomic parallels in feline oral squamous cell carcinoma (FOSCC). This spontaneous cancer in cats exhibits biological behaviors and clinical outcomes that closely resemble human disease. By analyzing 36 matched feline tumors, the study identified critical genetic mutations and copy number variants that mirror human head and neck squamous cell carcinoma (HNSCC). Consequently, these findings reinforce the value of feline models in comparative oncology research.
The investigation revealed that the TP53 gene harbored consequential variants in 71% of FOSCC tumors. This finding is particularly noteworthy because TP53 remains the most frequently mutated gene in human HNSCC. Furthermore, the study identified recurrent copy number variants (CNVs) in essential genes such as CDKN2A, PTEN, and MYC. Although the overall tumor mutational burden was relatively low, the genomic landscape parallels HPV-negative HNSCC in humans. Similarly, variants in genes like TTN, FSIP2, and LRP1B were identified, though at lower frequencies.
Moreover, the researchers observed that recurrent small-scale mutations were uncommon aside from TP53. However, the presence of frequent CNVs indicates a complex genetic architecture driving the disease. Interestingly, six feline subjects had a long history of chronic gingivostomatitis before their cancer diagnosis. This suggests that chronic inflammation or viral infections might contribute to tumorigenesis in younger patients. Therefore, clinicians can view FOSCC as a genetically heterogeneous cancer with a multifactorial cause.
Additionally, the similarities in treatment resistance and loco-regional recurrence highlight the potential for shared therapeutic targets. Understanding these HNSCC genomic parallels allows scientists to evaluate new drugs in a spontaneous animal model before human trials. This approach aligns with the One Health initiative, which seeks to improve medical outcomes for both humans and animals. Consequently, further study into feline genomics may accelerate the development of precision medicine for head and neck cancers.
Both cancers frequently harbor mutations in the TP53 gene and exhibit copy number variants in CDKN2A and MYC. These shared markers indicate that the underlying oncogenic drivers are strikingly similar across both species.
The study indicates that the genomic landscape of feline oral cancer parallels HPV-negative HNSCC. This is characterized by low tumor mutational burden but high rates of TP53 mutations and copy number alterations.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical or veterinary advice. Refer to the latest local and national guidelines for clinical practice.
References
Chu S et al. Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma. Vet Comp Oncol. 2026 Feb 22. doi: 10.1111/vco.70054. PMID: 41725028.
Francis BA et al. The oncogenome of the domestic cat. Science. 2026;387(6780):eadn1234. doi: 10.1126/science.adn1234.
The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576-582. doi: 10.1038/nature14129.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study using whole exome sequencing reveals that feline oral cancer shares key genomic similarities with human HPV-negative head and neck cancer....
8 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today